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Kaposi’s sarcoma-associated herpesvirus (KSHV), also known as human herpesvirus 8 (HHV8), has significant sequence homology to
Epstein–Barr virus (EBV). In cell culture, HHV8 is primarily latent, and viral genes associated with lytic replication are not expressed. Two
lytic origins of DNA replication (oriLyt) are present within the HHV8 genome and are composed of an AT-rich region adjacent to GC-rich
DNA sequences. We have now identified essential cis- and trans-acting elements required for oriLyt-dependent DNA replication. The
transient replication assay was used to show that two AT-rich elements, three consensus AP1 transcription factor-binding sites, an ORF50
response element (RE), and a consensus TATA box motif are essential for efficient origin-dependent DNA replication. Transient transfection
of luciferase reporter constructs indicated that the downstream region of the HHV8 oriLyt responds to ORF50 and suggests that part of the
oriLyt may be an enhancer/promoter. In addition, a transient cotransfection–replication assay elucidated the set of trans-acting factors
required for lytic DNA replication. These factors consist of homologues to the core replication proteins: ORF6 (ssDNA binding protein),
ORF9 (DNA polymerase), ORF40-41 (primase-associated factor), ORF44 (helicase), ORF56 (primase), and ORF59 (polymerase
processivity factor) common to all herpesviruses along with ORF50 (K-Rta) and K8 (K-bZIP).
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Introduction HHV8 early gene promoters and is the product of a multiplyHuman herpesvirus 8 (HHV8) is a g herpesvirus closely
related to herpesvirus saimiri (HVS) and Epstein–Barr virus
(EBV) (Chang et al., 1994). In cell culture, lytic replication
of HHV8 is limited to a few cells where a majority of
infected cells contain virus in the latent state (Miller et al.,
1996, 1997; Renne et al., 1996).
The lytic phase of replication can be induced by treatment
with tetradecanoyl phorbol acetate, n-butyrate, or transfec-
tion of a plasmid expressing the viral transactivator K-Rta
(Gradoville et al., 2000; Lukac et al., 1998; Renne et al.,
1996; Sun et al., 1998, 1999). K-Rta interacts with some822/$ - see front matter D 2003 Elsevier Inc. All rights reserved.
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ail address: gpari@unr.edu (G.S. Pari).spliced transcript containing a basic amino acid region (BR),
a leucine zipper (LZ) motif, and an activation domain (Song
et al., 2002; Wang et al., 2001a). K-Rta was shown to activate
two delayed early genes, ORF57 and K-bZIP, by direct DNA
binding to their promoters (Lukac et al., 2001). In addition to
the transcriptional activation of these viral promoters, K-Rta
also regulates its own expression via an octamer-binding
sequence (Deng et al., 2000; Sakakibara et al., 2001).
Using the transient replication assay, all of the trans-
acting factors required for EBV, human cytomegalovirus
(HCMV), and herpes simplex virus type 1 (HSV-1) origin-
dependent DNA replication have been elucidated (Fixman
et al., 1992; Pari et al., 2001; Sarisky and Hayward, 1996;
Wu et al., 1988). Common to all these viruses is the
requirement of six core replication proteins for origin-
dependent DNA replication: DNA polymerase, processivity
factor, helicase, primase, primase-associated factor, and a
D.P. AuCoin et al. / Virology 318 (2004) 542–555 543ssDNA binding protein. In addition to these core proteins,
each virus encodes an initiator or origin binding protein. In
EBV, the protein Zta is required for origin-dependent DNA
replication and serves to activate transcription as well as
play a direct role in DNA replication (Chang et al., 1990;
Sarisky et al., 1996). In the case of HHV8, evidence to date
appears to indicate that K-Rta serves as the major trans-
activator of gene expression. However, another protein
displaying delayed early kinetics, K-bZIP (K8, RAP), is
postulated to be the initiator protein and may have a direct
role in the initiation of DNA replication (Lin et al., 2003).
A number of herpesvirus lytic origins have been identi-
fied and characterized (Anders and Punturieri, 1991; Anders
et al., 1992; AuCoin et al., 2002; Hammerschmidt and
Sugden, 1988; Pari et al., 2001; Stow, 1982; Stow and
Davidson, 1986). On the basis of these findings, several
common features have become apparent. For example, AT-
rich regions that are presumably sites where DNA is melted
or unwound, several transcription factor-binding sites, and
promoter enhancer regions, which are associated with active
transcription or assembly of the transcription machinery, all
have been identified within herpesvirus lytic origins. Re-
cently, we identified two lytic origins of replication within
the HHV8 genome (AuCoin et al., 2002). These lytic origins
closely resemble the lytic origin of a related herpesvirus,
rhesus macaque rhadinovirus (RRV) (Pari et al., 2001). Both
RRV and HHV8 lytic origins have GC-rich regions adjacent
to an AT-rich region. Initial mapping studies indicated that
replication was dependent on the presence of the AT-rich
region and a portion of GC-rich region (AuCoin et al., 2002;
Pari et al., 2001). We have now further characterized the
HHV8 oriLyt region and have identified several specific
motifs that contribute to oriLyt function. The transient
replication assay determined that the HHV8 oriLyt utilizes
two AT-rich elements and an ORF50 response element (RE)
that is responsive to K-Rta in transient reporter assays. Also,
using HHV8 oriLyt in a cotransfection–replication assay,
we have elucidated all of the trans-acting factors required
for origin-dependent DNA replication. In addition to the six
core replication proteins, the transient replication assay
revealed that K-Rta and K-bZIP are required for DNA
replication. These results suggests that in contrast to EBV
origin-dependent DNA replication, HHV8 lytic replication
may utilize the transcriptional activation conveyed by K-Rta
along with an as yet undefined activity supplied by K-bZIP.Results
Efficient replication of HHV8 oriLyt is dependent upon intact
AT-rich sequences, three AP1 transcription factor-binding
sites, and a downstream component containing an ORF50RE
and a TATA box
Initial characterization of the HHV8 oriLyt identified a
minimal origin mapping between nucleotides 23069 and24619 for the leftward origin oriLyt-L. Since the nucleotide
sequence is almost identical (>99%) for oriLyt-L and oriLyt-
R, all experiments described in this report will use oriLyt-L.
Fig. 1 shows the nucleotide sequence for HHV8 oriLyt-L
along with various DNA elements of interest. Two AT-rich
regions are present at the leftward or 5V-end of the sequence.
The most 5VAT-rich region is a perfect palindrome whereas
the other region is a TATATA(n) repeat element (Fig. 1).
Also, three AP-1 transcription factor-binding sites and an
ORF50RE are present just upstream of a consensus TATA
box toward the rightward end of the origin (Fig. 1).
Although the 5Vand 3V boundaries of oriLyt were previ-
ously mapped, we next wanted to identify essential regions
that contributed to DNA replication. Deletion mapping of
oriLyt revealed that the AT-rich elements and sequence
further downstream were essential for oriLyt function (data
not shown). To investigate which specific elements contrib-
ute to DNA replication, we generated several site-directed
mutant plasmid constructs for oriLyt. These constructs were
transfected into BCBL-1 cells and assayed for replication
efficiency using a control un-mutagenized construct (pAlter-
Age/Mlu) as the reference signal on a Southern blot. Each
transfection was performed 4 times and a representative
experiment is presented in Fig. 2, panels B and C. Fig. 2A is
a schematic of oriLyt-L showing the relative position of
each mutated element.
Initial inspection of the HHV8 oriLyt region revealed
that the organization of this lytic origin is similar to EBV
with respect to the presence of transcription factor-binding
sites and elements that act as substrates for specific viral
encoded factors. The HHV8 oriLyt contains three consen-
sus AP1 transcription factor-binding sites (Fig. 1). Since
these elements function as Zta binding sties in EBV, we
wanted to determine if these sites play a role in HHV8
replication. Initial mutations, where only one or two of
these elements were mutated, decreased the replication
markedly (data not shown). Base pair changes introduced
into all three AP1 transcription factor-binding sites had a
lethal effect on replication (Fig. 2B, lane: AP1 sites). This
indicated that these elements play a significant role in the
HHV8 oriLyt.
Also present on the leftward side of the HHV8 oriLyt are
two A + T rich regions. These A + T rich regions can also be
found within the EBV oriLyt region. Consequently, we
wanted to determine if this region was essential for oriLyt-
dependent DNA replication. We generated a construct with
a 5 bp mutation (changing 5 adenosine bases to 5 cytosine
bases) in each A + T element and tested this plasmid in the
replication assay. Mutation of the A + T rich regions within
the HHV8 oriLyt also abrogated replication (Fig. 2B, lane:
AT(A) and AT(B)). This result confirms a recent finding
showing that these regions act as substrates for the putative
initiator protein K-bZIP (Lin et al., 2003).
The right half (3V-end) of the HHV8 oriLyt encodes two
elements that are usually associated with the regulation of
gene expression. The HHV8 transactivator protein K-Rta
Fig. 1. Schematic of the HHV8 genome indicating the relative position of oriLyt-L and oriLyt-R. The figure shows DNA sequence of the oriLyt-L region corresponding to nts 23069–25062. Indicated are two AT-
rich elements, three AP-1 transcription factor-binding sites, an ORF50 response element (ORF50RE), and a consensus TATA box.
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Fig. 2. Efficient replication of HHV8 oriLyt requires intact AT-rich DNA elements and a downstream region containing an ORF50 RE and a TATA box. (A)
Schematic of oriLyt DNA sequence indicating the relative positions of selected motifs subjected to mutagenesis. (B) Autoradiogram of Southern blot of DNA
from BCBL-1 cells transfected with various oriLyt subclones having base pair changes in identifiable DNA motifs. Total cellular DNA was harvested 4 days
post-transfection and cleaved with EcoRI and DpnI, replicated plasmid bands are shown. Descriptions of plasmids are detailed in Materials and methods.
Control lane contains wild-type oriLyt subcloned in the pAlter vector. Lane AP1 sites contains a plasmid that has a 3-base pair change in each of the identified
AP1 transcription factor-binding sites; lane AT(a)and AT(B) contains a plasmid that has a 5-base change in both A + T(A) and A + T(B) elements. (C) The ORF50
RE and TATA elements are essential for origin function. Autoradiogram of a Southern blot of DNA from cells transfected with either an oriLyt subclone with a
mutated ORF50RE or an oriLyt subclone that mutated both the TATA motif and the ORF50 RE or an oriLyt subclone that mutated the TATA box alone. Lane
ORF50 RE contains a plasmid that has a 3-base pair change in the ORF50 RE; lane TATA has a 3-base pair change in the TATA motif; lane TATA and ORF50
RE contains mutations in both the TATA and ORF50 RE motifs. (D) Confirmation of the requirement for HHV8 DNA motifs using an internal control
replication plasmid in the transient replication assay. Mutated plasmid constructs were cotransfected along with a replication competent HHV8 oriLyt plasmid.
Replication products for the control plasmid, pDA15, and un-mutagenized pAlter construct are shown in the control lane. Lanes designated AP1 sites, AT(a)and
AT(B), ORF50 RE, TATA, and TATA and ORF50 RE each contain the mutated plasmid constructs and pDA15.
D.P. AuCoin et al. / Virology 318 (2004) 542–555 545was shown to interact with a DNA element found in the
upstream promoter region of the polyadenylated nuclear
(PAN) RNA gene. This motif, an ORF50RE, is also
present within the oriLyt region of HHV8 (Fig. 1). Further
downstream from the ORF50RE is a consensus TATA box
(Fig. 1), again suggesting that transcription may play a role
in oriLyt function. oriLyt subclones that had 5-base pair
changes in the ORF50RE reproducibly failed to replicate,indicating that this motif was essential for DNA replication
(Fig. 2C, lane: ORF50 RE). A subclone that had base pair
changes such that the TATA motif was mutated to CTGA
also failed to replicate, indicating dependence for an intact
TATA element for efficient lytic replication (Fig. 2C, lane:
TATA). An oriLyt construct in which both the TATA
element and the ORF50 RE were mutated resulted in the
complete loss of replication signal (Fig. 2C, lane: TATA
D.P. AuCoin et al. / Virology 318 (2004) 542–555546and ORF50 RE). This indicated that efficient oriLyt
amplification required an intact ORF50 RE and TATA
motif.
In order to ensure that the lack of replication signal for
mutant plasmids was authentic, we again performed the
transient replication assay, except that an internal control
was added to the transfection mixture. BCBL-1 cells were
cotransfected with the pAlter plasmid along with the HHV8
oriLyt plasmid pDA15. pDA15 contains the exact DNA
sequence subcloned into pAlterAge/Mlu, except that it is
ligated into pGEM7zf (AuCoin et al., 2002). By performing
this cotransfection, we were able to compare the replication
efficiency of mutagenized plasmids to a replication compe-
tent control plasmid within the same transfection. Since the
pAlter vector is larger than pGEM, these plasmids can be
resolved in an agarose gel. When cotransfections were doneFig. 3. Identification of a promoter element within the rightward half of HHV8 o
regions. Indicated are the positions of various DNA elements and an enhancer regi
and a TATA motif was subcloned into a luciferase reporter construct and transfe
contains DNA sequence encoding both the ORF50RE and TATA elements. Plasm
includes the TATA element. Plasmid ORILUC3 contains DNA sequence upstrea
contains the same sequence as ORILUC1 except in the reverse orientation. Plasm
Plasmids ORILUC6, ORILUC7, and ORILUC8 contain small (50 bp) regions be
BCBL-1 cells transfected with pKS50. Lanes 1, BCBL-1 RNA hybridized with the
nts 24250!24450; 2, BCBL-1 RNA from cells transfected with pKS50 and in
transcription) single-stranded riboprobe corresponding to nts 24250!24450; 3, BC
stranded riboprobe corresponding to nts 24450!24250.using the un-mutagenized pAlterAge/Mlu oriLyt plasmid
along with pDA15, both plasmids replicated efficiently (Fig.
2D, control lane). However, when cotransfections were
performed using the mutagenized versions of pAlterAge/
Mlu, no replication signal could be detected for the pAlter
vectors confirming the results of the replication assays in
Figs. 2B and C (Fig. 2D).
Although all of the essential DNA motifs within HHV8
oriLyt are not yet defined, many of the identified elements
appear in both EBV and HHV8 oriLyt regions. Fig. 3A
shows a comparison between EBV and HHV8 oriLyt
regions indicating the presence of AT-rich domains and
AP-1 or Z-response elements (ZRE). Also, within EBV
oriLyt are two Rta response elements. EBV Rta is a trans-
activator protein that can augment lytic DNA replication and
is homologous to K-Rta.riLyt. (A) Schematic of a comparison of HHV8 and EBV cis-acting oriLyt
on of the EBVoriLyt. (B) The HHV8 oriLyt region containing an ORF50RE
cted into Vero cells with and without K-Rta. Plasmid construct ORILUC1
id ORILUC2 contains DNA sequence downstream of the ORF50RE and
m of the TATA element and includes the ORF50RE. Plasmid ORILUC4
id ORILU4C5 contains the region between the TATA and the ORF50 RE.
tween the TATA and ORF50 RE of oriLyt. (C) Northern blot of RNA from
sense (left to right transcription) single-stranded riboprobe corresponding to
cubated with 500 Ag/ml PFA and hybridized with the sense (left to right
BL-1 RNA hybridized with the antisense (right to left transcription) single-
rology 318 (2004) 542–555 547The rightward end of the HHV8 oriLyt is responsive to K-
Rta and is a region of active transcription within the viral
genome
Since DNA sequence from the rightward end of the
HHV8 oriLyt is required for efficient replication, and this
region contains elements found in other HHV8 gene pro-
moters, we tested the ability of this region to respond to K-
Rta using a luciferase reporter assay. We constructed re-
porter plasmids containing the rightward end of the HHV8
oriLyt that encoded either the intact ORF50RE and TATA
motif or control plasmids that encoded only the TATA or
ORF50RE (Fig. 3B). In addition, the region containing the
intact ORF50RE and TATA motif was subcloned into the
reporter plasmid in the reverse orientation. Reporter con-
structs containing both the ORF50RE along with the TATA
motif strongly responded to K-Rta in the transient reporter
assay (Fig. 3B, ORILUC1). This response was not affected
by the addition of K-bZIP to the transfection mixture (data
not shown). Constructs in which either the ORF50RE or the
TATA was deleted displayed a weaker response to K-Rta
(Fig. 3B, ORILUC2 and ORILUC3). A construct that
contained both the ORF50RE and TATA elements in the
reverse orientation failed to respond to K-Rta (Fig. 3B,
ORILUC4). A construct in which both the ORF50RE and
the TATA motifs were deleted failed to respond to K-Rta in
the transient assay (Fig. 3B, ORILUC5). In addition, con-
structs containing DNA sequence internal to the TATA and
the ORF50RE failed to respond to K-Rta (Fig. 3B, ORI-
LUC6, ORILUC7, and ORILUC8). A luciferase construct
encoding the PAN promoter was used as a positive control
for a K-Rta induced response (Fig. 3B, PAN). These results
indicate that the rightward half of the HHV8 oriLyt is
responsive to K-Rta and suggests that this region may
contribute an essential promoter function to facilitate lytic
replication.
Since promoter activity was observed using the transient
assay, we were interested in determining the transcription
pattern associated with this region of the HHV8 oriLyt. We
initially generated single-stranded probes such that the
entire oriLyt region was covered. However, transcripts were
only detected in the region down stream of the TATA box
(data not shown). For a more detailed analysis of transcrip-
tion from this region, we generated strand-specific ribop-
robes corresponding to nts 24250–24450 of the viral
genome. This probe is complementary to the region just
downstream of the TATA box located at nts 24201–24207.
Probes were made such that transcripts originating from
each DNA strand within the virus could be detected. BCBL-
1 cells were transfected with an ORF50 expression con-
struct, and total cellular RNA was extracted and separated
on a formaldehyde agarose gel. RNA was transferred to a
nylon membrane and Northern blots were performed. When
riboprobes were used corresponding to transcripts oriented
in the rightward direction (sense), an approximately 450-bp
band was detected (Fig. 3C, lane 1). This RNA transcript
D.P. AuCoin et al. / Viwas not affected by the presence of PFA (Fig. 3C, lane 2).
However, when a riboprobe complementary to transcripts
originated from the leftward direction (antisense), no band
was detected (Fig. 3C, lane 3). No RNA transcripts were
detected from BCBL-1 cells that were not transfected with
the ORF50 expression construct (not shown). This result
strongly suggests that the region of oriLyt containing the
ORF50 RE and TATA box is a promoter responsible for
active transcription, and that transcription or the assembly of
transcription machinery (directed by ORF50) may be re-
quired for HHV8 lytic DNA replication.
The core replication proteins along with K-Rta and K-bZIP
are required for origin-dependent DNA replication
Once we identified the HHV8 lytic origin, the next step
was to use this cis-acting element as a reporter to elucidate
the trans-acting factors necessary and sufficient for origin-
dependent DNA replication. The cotransfection–replication
assay takes advantage of the fact that all of the required
factors for lytic replication can be supplied ‘‘in trans’’ by
cotransfecting HHV8 subgenomic fragments that, in this
case, initially spanned the entire viral genome. This method
has been successfully employed in other herpesvirus sys-
tems (Fixman et al., 1992; Pari and Anders, 1993; Wu et al.,
1988). For HHV8, we initially used a cosmid library
consisting of existing cosmids along with cosmids con-
structed in our laboratory. This library, consisting of over-
lapping cosmids, was transfected into Vero cells along with
pKS50 (K-Rta expression construct) and the HHV8 oriLyt
containing plasmid pDA13 (AuCoin et al., 2002). We
included a plasmid that overexpressed K-Rta in transfec-
tions using cosmid clones because previous studies with
HCMV and RRV indicated that a detectable replication
signal was achieved when viral transactivators were includ-
ed in the transfection mixture even though a genomic copy
was present on input cosmid clones (Pari et al., 1993, 2001).
Fig. 4A is a schematic of the HHV8 genome showing the
location of the putative replication ORFs and the cosmid
library used to complement origin-dependent DNA replica-
tion. Table 1 shows the location of each replication gene and
the names of the expression constructs used in the replica-
tion assay.
A replication signal was detected when cosmid clones
Z6, 1, Z8, and H were transfected along with oriLyt,
demonstrating that these cosmids encoded all the necessary
factors for oriLyt-dependent DNA replication (Fig. 4B, lane
2). No replication product was detected in cosmid trans-
fections omitting the K-Rta expression construct, again
confirming that addition of this protein was necessary to
detect a replication signal even when Rta is encoded by a
transfected cosmid clone (Fig. 4B, lane 3). In addition, no
replication signal was observed when the oriLyt-containing
plasmid pDA13 was omitted from transfection mixtures
(Fig. 4B, lane 1). Cosmid H was replaced by a genomic
subclone encoding both K-Rta and K-bZIP, demonstrating
Fig. 4. Elucidation of factors required for HHV8 oriLyt-dependent DNA replication using the cotransfection– replication assay. (A) Schematic of the HHV8
genome showing the relative position of putative replication ORFs and cosmid clones used in the cotransfection assay. Shown are the candidate replication
ORFs and the subclones used in cotransfections to elucidate required factors. (B) Replication assay using HHV8 oriLyt and cosmid or plasmid subclones. Vero
cells were transfected with various cosmids and plasmids along with pDA13. Shown is an autoradiogram of Southern blots of EcoRI and DpnI cleaved total
cellular DNA from various cotransfections hybridized with pGEM7zf(). DpnI-resistant replicated plasmid band is shown. Lanes 1, cosmids Z6, 1, H, Z8,
plasmids pKS50 (oriLyt); 2, cosmids Z6, 1, H, Z8, plasmids pKS50 and pDA13; 3, cosmids Z6, 1, H, Z8, and pDA13 (K-Rta); 4, cosmids Z6, 1, Z8, plasmids
pKS50-K8 and pDA13; 5, cosmids Z6, 1, plasmids pKS8, pKS56, pKS59, pKS50, and pDA13; 6, cosmids Z6, 1, plasmids pKS50-K8, pKS56, pKS59, and
pDA13; 7, cosmids Z6, 1, plasmids pKS50, pKS56, pKS59, and pDA13; 8, pKS6, pKS9, pKS40–41, pKS44, pKS56, pKS59, pKS50, pKS8, and pDA13; 9,
pKS6, pKS9, pKS40–41, pKS44, pKS56, pKS59, pKS50, and pDA13; 10, pKS6, pKS9, pKS40–41, pKS44, pKS56, pKS59, pKS8, and pDA13; 11, pKS6,
pKS9, pKS40–41, pKS44, pKS56, pKS59, pKS50-K8, and pDA13; 12, pKS6, pKS9, pKS40–41, pKS44, pKS56, pKS50, pKS8, and pDA13 (ORF59); 13,
pKS6, pKS9, pKS40–41, pKS44, pKS59, pKS50, pKS8, and pDA13 (ORF56); 14, pKS6, pKS9, pKS40–41, pKS44, pKS56, pKS59, pKS50, pKS8, and
pDA13; 15, pKS9, pKS40–41, pKS44, pKS56, pKS59, pKS50, pKS8, and pDA13 (ORF6); 16, pKS6, pKS40–41, pKS44, pKS56, pKS59, pKS50, pKS8,
and pDA13 (ORF9); 17, pKS6, pKS9, pKS40–41, pKS44, pKS56, pKS59, pKS50, pKS8, and pDA13; 18, pKS6, pKS9, pKS44, pKS56, pKS59, pKS50,
pKS8, and pDA13 (ORF40-41); 19, pKS6, pKS9, pKS40–41, pKS56, pKS59, pKS50, pKS8, and pDA13 (ORF44).
D.P. AuCoin et al. / Virology 318 (2004) 542–555548that the replication assay could be performed using only
cosmids Z6, 1, and Z8 (Fig. 4B, lane 4). Since previously
published information identified all putative replication
ORFs, we subcloned the replication gene homologues into
expression vectors such that the inserted gene was expressed
from the HCMV major immediate-early promoter (MIEP).
Further cosmid substitution experiments demonstrated that
cosmid Z8 contributed ORF59 and ORF56 (Fig. 4B, lane 6);
in addition, the genomic subclone encoding K-Rta and K-
bZIP was replaced by two cDNA constructs, one encoding
only K-bZIP and the other expressing K-Rta (Fig. 4B, lane
5). No replication signal was detected in samples omitting
the K-bZIP cDNA plasmid, demonstrating that this ORF isTable 1
Subclones used in transient cotransfection replication assay
Gene Cosmid location P
ORF6 Z6 S
ORF9 Z6 D
ORF40/41 1 and H P
ORF44 1 and H H
ORF56 Z8 and H P
ORF59 Z8 and 13B P
ORF50 H T
ORF57 Z8 and H T
K8 (K-bZIP) H O
a Subclone encodes ORF50 and K8.
b Subclone encodes only ORF50.
a K8 cDNA obtained from pcDNA3.1.K-bZIP (Ganem).required for replication (Fig. 4B, lane 7). Confirmation that
K-Rta and K-bZIP were required for DNA replication was
demonstrated by a lack of any detectable signal in samples
where either K-bZIP or K-Rta cDNA clones were omitted
from transfection mixtures in the replication assay (Fig. 4B,
lanes 9 and 10), respectively). It was also shown that a
genomic subclone encoding both K-bZIP and K-Rta also
complemented DNA replication (Fig. 4B, lane 11). Omis-
sion experiments, where one ORF at a time was not
included in transfection mixtures, demonstrated that the
replication genes: ORF59 (Fig. 4B, lane 12), ORF56 (Fig.
4B, lane 13), ORF6 (Fig. 4B, lane 15), ORF9 (Fig. 4B, lane
16), ORF40-41 (Fig. 4B, lane 18), and ORF44 (Fig. 4B,utative protein Subclone
ingle-stranded DNA binding pKS6
NA polymerase pKS9
rimase-associated factor pKS40-41
elicase pKS44
rimase pKS56
o1 processivity factor pKS59
ransacting factor pKS50-K8a, pKS50b
ransacting factor
rigin binding (?) pKS8c
Fig. 5. Identification of protein domains essential for K-bZIP activity in the cotransfection–replication assay. (A) Location of truncations within the K-bZIP
protein. Also shown are the regions of various protein domains: NLS (nuclear localization signal), BR (basic amino acid region), LZ (leucine zipper domain).
(B) Expression of K-bZIP truncation mutants. Western blot of FLAG-tagged K-bZIP truncation mutants detected using anti-FLAG antibody. Lanes 1–5
correspond to truncations 1–5 in panel A. (C) Cotransfection– replication assay containing all the necessary factors required for oriLyt-dependent DNA
replication except that K-bZIP truncation mutants were substituted for wt K-bZIP. Cotransfection replication assay substituting leucine zipper mutants of K-
bZIP for wild-type K-bZIP. Lanes 1, wt K-bZIP; 2, cotransfection containing K-bZIP truncation mutant 2; 3, cotransfection containing K-bZIP truncation
mutant 3; 4, cotransfection containing K-bZIP truncation mutant 4; 5, cotransfection containing K-bZIP truncation mutant 5.
D.P. AuCoin et al. / Virology 318 (2004) 542–555 549lane 19) were all required for oriLyt-dependent DNA
replication. To ensure that the observed replication signal
is due to plasmid replication and not incomplete DpnI
cleavage, we performed a replication assay in which the
transfection contained all required replication genes and
cleaved extracted DNA with a mixture of DpnI/EcoRI and
MboI (data not shown). MboI cleaves unmethylated DNA
and is inhibited by methylated DNA. If incomplete DpnI
cleavage was occurring, a replication signal would still be
detected; however, no signal was observed. This confirms
that replication was due to DNA amplification of oriLyt.
Two regions of the K-bZIP protein are essential for
complementation of oriLyt replication
In order to investigate the functional domains of the K-
bZIP protein contributing to lytic DNA replication, we
made various truncation mutants and tested them for their
ability to complement DNA replication in the transient
replication assay. We generated a set of four truncation
mutants, two of these constructs had sequence deleted
from the N-terminus and two other constructs deleted a
portion of the C-terminus of the K-bZIP polypeptide (Fig.
5A). Each construct was made such that the FLAG epitope
was fused in frame with the K-bZIP protein, and expres-
sion was confirmed by Western blot using anti-FLAG
antibody (Fig. 5B). These constructs were used in the
cotransfection–replication assay and substituted in theplace of wild-type (wt) K-bZIP. Transfection mixtures
contained all of the factors determined to be necessary
for oriLyt-dependent DNA replication. Only one of the K-
bZIP truncation mutants was capable of complementing
DNA replication. A construct that has 65 aa deleted from
the N-terminus retained activity in the replication assay
and was able to complement replication of pDA13 (Fig.
5C, lane 2). A construct deleting 100 aa from the N-
terminus failed to complement DNA replication, suggest-
ing that an essential domain lies within this region (Fig.
5C, lane 3). Also, constructs containing K-bZIP deletions
that removed part of the leucine zipper (LZ) motif and the
basic amino acid region (BR) failed to complement oriLyt
replication (Fig. 5C, lanes 4 and 5), respectively). These
experiments indicated that K-bZIP protein domains map-
ping from aa 65 to 100 and a region 35 aa from the C-
terminus (deleting the leucine zipper motif) contribute an
essential replication function.
The K-bZIP leucine zipper motif is essential for activity
Truncation mutants of K-bZIP indicated that when the
leucine zipper region was deleted from the protein, no oriLyt
replication products were detected. Since leucine zipper
motifs are important for dimerization, we chose to mutate
the leucine amino acids within the leucine zipper domain of
the protein and evaluate the ability of K-bZIP to comple-
ment DNA replication.
Fig. 6. The leucine zipper of K-bZIP is required for efficient oriLyt-
dependent DNA replication. (A) Mutation of leucine residues within the K-
bZIP leucine zipper motif. Western blot of leucine zipper mutants of K-
bZIP. (B) Shown is a schematic of the K-bZIP protein indicating the
translational start and stop codons and the basic amino acid region upstream
of the leucine zipper motif. Leucine amino acid residues are shown as the
letter ‘‘L’’, those within a gray circle are considered part of the heptad repeat
structure comprising the leucine zipper motif. All transfections contained
the entire essential core replication proteins, pDA13 and pKS50. Control
lane contained wild-type K-bZIP expression plasmid. K-bZIP mutation
plasmids descriptions are listed in Materials and methods.
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identifiable leucine zipper motif in K-bZIP. However, only
four of these leucine residues are considered part of the
heptad repeat constituting the putative leucine zipper do-
main (Lin et al., 1999). Those leucine residues that are part
of the heptad repeat structure are shown as having gray
circles around them in Fig. 6B. Since no functional assay to
date has determined which leucine residues within K-bZIP
contribute to activity of the protein, we chose to target all of
the leucine amino acid residues within the leucine zipper
motif. Using a site-directed mutagenesis technique, we
introduced base pair changes into the coding sequence of
K-bZIP such that the hydrophobic leucine residues weremutated. Five mutant constructs were generated, each
contained 1–4 amino acid changes within the leucine
residues. Leucine zipper mutant constructs were evaluated
for expression by transfection into Vero cells and subse-
quent Western blot analysis. Expression levels for all
mutants were found to be similar (Fig. 6A). These con-
structs were cotransfected along with plasmids encoding all
the other required replication proteins and oriLyt, except
that the mutagenized K-bZIP constructs were substituted for
wild-type (wt) K-bZIP. The K-bZIP construct that had
leucine (a) mutated was still capable of complementing
oriLyt-dependent DNA replication (Fig. 6B, lane: pLZ8-
1). However, the replication signal was reduced significant-
ly from wt K-bZIP (Fig. 6B, compare lanes Control to
pLZ8-1). Constructs with the two leucine residues (e) and
(f) mutated, even further reduced the replication single
compared to wt K-bZIP (Fig. 6B, compare lanes Control
to pZL8-3). However, no replication signal was detected
when the two leucine residues (a) and (b) were changed
within the leucine zipper motif of K-bZIP (Fig. 6B, lane:
pZL8-2). When changes were introduced to leucine residues
(c), (d), (e), and (f), again no replication signal was detected
(Fig. 6B, lane: pZL8-4). These experiments revealed that the
leucine amino acid residues within the leucine zipper motif
are essential for K-bZIP replication function.Discussion
HHV8 lytic replication appears to play a role in the
pathogenesis of Kaposi’s sarcoma (KS). One study has
demonstrated that the use of the drug ganciclovir, an
inhibitor of herpesvirus polymerase, can affect the course
of KS in AIDS patients (Martin and Osmond, 1999). Lytic
gene expression also supplies many of the proteins that
control angiogenesis and possible immune evasion (Bais et
al., 1998; Kirshner et al., 1999; Nador et al., 2001). The
strongest evidence to date implicating HHV8 as the cause of
clinical disease comes from reports on the transforming
ability of the virus (Flore et al., 1998; Sturzl et al., 2001). It
was shown that purified HHV8 could infect and transform
primary human endothelial cells in culture. More recent
studies demonstrated that there is an up-regulation of
vascular endothelial growth factors (VEGFs) in HHV8-
transformed endothelial cells along with an HHV8-induced
up-regulation of c-kit proto-oncogene (Masood et al., 2002;
Moses et al., 2002).
We have identified several key DNA elements within the
cis-acting HHV8 oriLyt that contribute to lytic DNA repli-
cation. Many of the identified motifs are common to other
previously characterized herpesvirus lytic origins. Similar to
EBV, HHV8 oriLyt contains a region composed of AT-rich
elements. A five base pair mutation in both the AT-rich
regions abrogated DNA replication, indicating that this
motif plays an important role in origin function. Absence
of a replication signal was also observed when the AP-1
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ments are of significance because EBV Zta, a viral trans-
activator and apparent origin-binding protein, is able to bind
to these elements (Fixman et al., 1995; Lieberman et al.,
1990). Recently, AP-1 sites, along with the AP-1 transcrip-
tion factor, were implicated as participating in the activation
of the ORF57 promoter along with K-Rta (Byun et al.,
2002).
The EBV oriLyt is composed of two regions. The first,
or upstream region, contains Zta response elements (ZREs)
and an AT palindrome (Hammerschmidt and Sugden, 1988;
Schepers et al., 1993, 1996). It has been shown that Zta
acts through ZREs and facilitates lytic DNA replication,
possibly with the aid of a cellular factor. The second EBV
oriLyt component is an enhancer/promoter that can be
replaced by the human cytomegalovirus (HCMV) immedi-
ate-early enhancer/promoter (Hammerschmidt and Sugden,
1988). HHV8 oriLyt appears to also have two components,
an upstream AT-rich region and a promoter region com-
posed of an ORF50RE present within the downstream
component of the origin. Mutations introduced into both
AT-rich regions did result in a loss of replication signal.
Mutations introduced into either the ORF50RE or the
downstream TATA box had a lethal effect with respect to
oriLyt amplification. Interestingly, the downstream compo-
nent of EBV oriLyt encodes two Rta-binding sites. ORF50,
an Rta homologue, may function in a similar manner in
HHV8, in that it may augment lytic replication along with
K-bZIP. Luciferase reporter assays demonstrated that the
downstream region in HHV8 contains a powerful promoter
that vigorously responded to K-Rta. This response was as
strong as the response previously observed with the PAN
promoter. This observation indicates a more complex
replication mechanism for HHV8 than EBV, in that two
viral encoded proteins are required for initiation of DNA
synthesis. The region continued to respond to K-Rta
stimulation, albeit at a much lower level, even when the
ORF50RE was not present in the reporter plasmid. This
could be due to the presence of additional as yet undefined
motifs that respond to the K-Rta protein. We are currently
investigating the precise motif within this region that
responds to K-Rta. However, it is apparent that the pres-
ence of the consensus ORF50RE is necessary for efficient
DNA replication, and more importantly, there is an indica-
tion that the role of K-Rta in DNA replication could be that
of an origin-specific transactivator. As was the case with
the PAN promoter, the ORF50 RE in oriLyt was unaffected
by the presence of K-bZIP.
The cotransfection replication assay originally developed
to elucidate herpes simplex virus type 1 (HSV-1) replication
proteins (Wu et al., 1988) was performed using HHV8
cosmids and subgenomic fragments. In HHV8, we identi-
fied and confirmed that the core replication proteins are
necessary for HHV8 oriLyt function. An earlier report had
used these HHV8 replication gene homologues to amplify
EBVoriLyt (Wu et al., 2001). We have now shown that twoadditional proteins, K-Rta and K-bZIP, are required for
HHV8 oriLyt function. K-Rta has been implicated as the
lytic switch protein and the transcriptional activator of many
HHV8 early kinetic class genes (Byun et al., 2002; Grado-
ville et al., 2000; Lukac et al., 1999, 2001; Wang et al.,
2001b, 2001c). K-Rta was shown to interact with CREB-
binding protein along with histone deacetylase, and these
interactions may suggest a mechanism by which K-Rta
modulates transcriptional activation and consequently the
switch from the latent to lytic cycles (Gwack et al., 2001). In
addition, K-Rta interacts with a cellular protein and this
interaction synergizes the transactivation activity of K-Rta
(Wang et al., 2001b, 2001c). It is a somewhat surprising
result that K-Rta was shown to have a direct role in DNA
replication. It was anticipated that K-Rta would function to
up-regulate HHV8 replication genes and not be required for
replication directly. However, data from the site-directed
mutagenesis of HHV8 oriLyt and the luciferase reporter
studies suggest that K-Rta might interact directly with the
origin similar to the interaction identified with many HHV8
promoters.
In EBV, Zta is required for origin-dependent DNA
replication and serves to activate transcription as well as
playing a direct role in DNA replication (Chang et al.,
1990; Sarisky et al., 1996). In addition, Zta has been shown
to interact with the EBV helicase replication protein, and
this interaction can direct Zta into replication compartments
(Liao et al., 2001). K8 or K-bZIP is the proposed homo-
logue for EBV Zta and may act as the origin binding or
initiator protein. The K-bZIP protein has no transactivation
activity itself and is the product of multiple splicing events
resulting in the presence of a leucine zipper motif within the
protein (Lin et al., 1999). The K-bZIP protein colocalized
with the promyelocytic leukemia protein (PML) bodies and
displayed a punctate nuclear pattern in transfected cells
(Katano et al., 2001; Wu et al., 2001). It was also deter-
mined that K-bZIP is a phosphoprotein, phosphorylated by
cyclin-dependent kinases (Polson et al., 2001). K-bZIP is
one of the genes transactivated by K-Rta expression and
until now was not shown to participate in DNA replication
(Gruffat et al., 1999; Lin et al., 1999). K-bZIP expression
appears to be autoregulated via a mechanism involving
CCAAT/enhancer-binding protein a (C/EBPa) and an in-
teraction with K-Rta (Wang et al., 2003). Recently, K-bZIP
was shown to be a co-regulator for transcription of certain
HHV8 genes (Izumiya et al., 2003). This regulation was
mediated by a physical interaction of K-bZIP with K-Rta.
In these studies by Izumiya et al., cotransfection of K-Rta
and K-bZIP resulted in the repression of the ORF57
promoter (normally up-regulated by K-Rta), whereas the
expression of PAN was unaffected by the overexpression of
K-bZIP. K-bZIP may function as the ‘‘true’’ origin-binding
protein or initiator protein by itself or as a heterodimer
complex with K-Rta. Our data indicate that the leucine
zipper motif is essential for a replication function in the
transient assay. Leucine zipper motifs are implicated as
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demonstrated that the formation of K-bZIP homodimers is
dependent upon the presence of the leucine zipper domain
(Lin et al., 1999).
The requirement for both K-Rta and K-bZIP in the
replication assay may be because these two proteins can
exist as a heterodimer. Although K-Rta can activate the
promoter element within oriLyt in the absence of any other
viral encoded protein, an additional replication function for
K-Rta may also occur. Similar to the activation of the PAN
promoter, the oriLyt promoter activity was unaffected by the
addition of K-bZIP to the transfection mixture (data not
shown). One hypothesis is that early in infection, K-Rta
serves to transactivate essential lytic genes. At later times,
K-bZIP interacts with K-Rta to repress this transactivation
function and direct it to a replication function. This idea is
supported, in part, by the observation that K-bZIP represses
the K-Rta transactivation of the ORF57 promoter but not the
PAN promoter. The same activation element (ORF50RE)
found within the PAN promoter is present within HHV8
oriLyt. Further experiments are needed to identify the exact
role of K-bZIP and K-Rta in lytic replication.Materials and methods
Cell culture
BCBL-1 cells (AIDS Research and Reference Reagent
Program) were propagated in RPMI supplemented with
20% heat-inactivated fetal bovine serum (FBS). Vero and
COS7 cells were grown in DMEM-supplemented 10%
FBS.
Plasmid and cosmid constructs
Expression plasmids used in the cotransfection replica-
tion assay were derived from PCR amplification of puta-
tive HHV8 replication genes, followed by TA cloning into
pTarget mammalian expression vector (Promega, Madison,
WI). pKS6 (single-stranded DNA binding protein) was
constructed by using the primers 5V-CTCCATGGATTA-
CAAGGATGACGACGATAAGGTCTCCATGGCGC-
TAAAGGG (which contained the FLAG epitope) and 3V-
CTACAAATCCAGGTCAGAGA. pKS9 (polymerase) was
constructed by using the primers 5V-AGATCATG-
GATTTTTTCAATCCATTTATCGACCC and 3 V-
TTAGCCCTACTTATCGTCGTCATCCTTGTAA-
TCGGGCGTGGGAAAAGTCACGGGA (containing a
FLAG epitope).pKS4041(primase associated factor) was
constructed using the primers 5V-CTCAATGGCAAC-
GAGCGAAGAAACG and 3 V-TCAAAATAAAGA-
TAAAAGCCTGG. pKS44 (helicase) was constructed by
using the primers 5V-GAGGGAGATGGACAGCTCG and
3V-TTAGCCCTACTTAT-CGTCGTCATCCTTGTAATCG-
TAGATCAGAGTAGTCTTGGGGT (containing a FLAGepitope). pKS56 (primase) was constructed by using the
primers 5V-TGTACCATGGAGACGACATACCGCC and 3V-
TTAGCCCTACTTATCGTCGTCATCCTTGTAAT-
CACTGGCCAGTCCCACTGGTA (containing the FLAG
epitope). pKS59 (polymerase processivity factor) was
constructed using the primers 5V-AATCATGCCTGTG-
GATTTTCACTA and 3V-TTAGCCCTACTTATCGTCGT-
CATCCTTGTAATCAATCAGGGGGTTAAATGTGGTTT
(containing a FLAG epitope).
A cDNA clone for K-bZIP was supplied by D. Ganem
(UC San Francisco), and R. Sun (UC Los Angeles) supplied
a cDNA subclone of K-Rta.
Cosmids Z6 and Z8 were obtained from the AIDS
reagent program. Cosmids 1, H, and 13B were constructed
using the Supercos 1 Cosmid Vector Kit (Stratagene, La
Jolla, CA). Briefly, HHV8 genomic DNA was partially
cleaved with BamHI and large genomic fragments were
ligated into the Supercos vector previously cleaved with
BamHI. The ligation products were then packaged into
phage using the Gigapack III gold packaging extract
(Stratagene). Bacterial cells were infected with the cosmid
containing phage, colonies were selected, and cosmids
were purified and sequenced. Cosmid 1 contains the
HHV8 genomic sequence from nucleotides 33 906–
68700, cosmid H contains nucleotides 56222–85821,
and cosmid 13b contains the sequence from 85878 to
129092.
Luciferase constructs and luciferase assay
All PCR products were ligated into pGL2-Basic (Prom-
ega) using restriction sites engineered into PCR primers.
Plasmid ORILUC1 was constructed using PCR primers 5V-
CGGGGTACCCAGAACATGGGTGGCTAAC-3V and 5V-
TCCTCGAGGTTACGGGTAAATCCAAGAGATCCGTC-
3Vcorresponding to nt coordinates 24101–24283. Plasmid
ORILUC2 was constructed using PCR primers 5V-
CGGGGTACCGCCTACATGGGCAGCTTGTCCT-3V and
5 V-CTCCTCGAGGTTACGGGTAAATCCAAGA-
GATCCGT-3V corresponding to nt coordinates 24120–
24283. Plasmid ORILUC3 was constructed using PCR
primers 5 V-GGTACCGAGCTCTGGGTCACTCTA-
CTGGGTTATTCT-3V and 5V-CTCCTCGAGGCGTTCCC-
GGCGAAGGGGTGTAA-3Vcorresponding to nt coordinates
23869–24199. Plasmid ORILUC4 was constructed using
PCR primers 5 V-CGGGGTACCCAGAACATGGG-
TGGCTAAC-3Vand 5V-TCCTCGAGGTTACGGGTAAATC-
CAAGAGATCCGTC-3V corresponding to nt coordinates
24101–24283 and cloned into pGL2-Basic in the opposite
orientation as ORILUC1. The PAN promoter luciferase
construct was made using PCR primers 5V-TATGAA-
GAGCTCTGGAGGTGCCAAGTTCGC-3V and 5V-TAGA-
TAGCTAGCTGGGCAGTCCCAGTGCTAAAC-3V. ORI-
LUC5 contains DNA sequence between the ORF50 RE
and the TATA box, and was constructed using primers 5V-
CGGGGTACCGCCTACATGGGCAGCTTGTCCT-3V and
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ORILUC6 was constructed by annealing the primer 5V-
GCCTACATGGGCAGCTTGTCCTACGGTTACGCC-
CATTTGAGACGGGTTA-3V and the reverse complement,
and ligating the dsDNA into pGL-2 Basic. ORILUC7 was
constructed by annealing the primer 5V-TGTCCTACGGT-
TACGCCCATTTGAGACGGGTTAACCAACTGTTA-
CACCC-3V and the reverse complement, and ligating the
dsDNA into pGL-2 Basic. ORILUC8 was constructed by
annealing the primer 5V-CCCATTTGAGACGGGTTAAC-
CAACTGTTACACCCCTTCGCCGGGAACGC-3V and the
reverse complement, and ligating the dsDNA into pGL2-
Basic.
For the luciferase assay, Vero cells were plated in 6-well
plates 24 h before transfection at which time luciferase
constructs (1 Ag) were either cotransfected with 2 Ag of
an K-Rta expression construct or pGEM. Cells were har-
vested 48 h post-transfection and assayed for luciferase
activity using a Zylux luminometer. Relative fold increase
is expressed as the measure of luciferase activity of lucif-
erase reporter constructs transfected with K-Rta versus those
transfected with pGEM. Error bars are the result of three
separate experiments.
Site-directed mutagenesis
Substitutions of nucleotides within the oriLyt were per-
formed using the Altered Sites II Mammalian Mutagenesis
System (Promega). Briefly, pAlterAge/Mlu was constructed
by cleaving pDA15 with AgeI and MluI and ligating this
fragment into the pAlter vector. Site-directed mutagenesis
was performed using the pAlterAge/Mlu as a starting point.
Mutagenic oligonucleotides were constructed that contained
the nucleotides to be mutated within the center of the
sequence. The oligonucleotides were then annealed to the
single-stranded pAlterAge/Eco plasmid along with an ampi-
cillin repair oligonucleotide. The mutant strand is then
elongated with T4 DNA polymerase followed by transfor-
mation into ES1301 bacterial strain. Plasmids were then
purified and transformed into JM109 bacterial cells and the
plasmids were purified. Mutated plasmids were confirmed by
DNA sequencing. Designations for DNA elements selected
for mutagenesis are shown in Fig. 2. Mutant plasmid con-
structs were enerated as follows using the pAlterAge/Mlu
construct as the parent vector (underlined bases indicated
changed nucleotides): Both A + T elements were mutated
using primers 5V-GATGGCGGCGCCCATGAAATGG-
CCAAAAATCCCCC TTTTTCGAGTCGCTCACGGTCC-
CACCTA-3V and CTCAGCTGCGCTAGGATTAAAGGA-
TTATATCCCCC TATATAGGAAAAATCAAAA -
CAAAACTCTAA-3V, which introduced a 5-base pair
change within the middle of the AT(A) region and AT(B). All
the AP1 sites were mutated by using primers 5V-
AATAGGGGCTGCGAACCCTCAGCTGCGCTAGG-3V, 5V-
AAATCCCAACCCCAACCCTCATCGGGCCCTAT-3V, and
5V-AGATTCCAGGCCCGACC CTCACTAGCCCCCCC-3V,which introduced a 3-base pair change into AP1(A,B and C)
sites. A mutation in the ORF50RE was generated using the
p r ime r 5 V- TGCCCATGTAGGCGTTAGCCATTT
ATGTTCTGGGGCGCGCCAGCG-3V. A mutation in the
TATA box was genera ted us ing the pr imer 5 V-
CTGCTGTCCCTCGTTTTTCAG GCGTTCCC -
GGCGAAGGG-3V. A 3-base pair mutation was introduced
into the TATA site using the primer 5V-CTGCTGTCCCT-
CGTTTTTCAGGCGTTCCCGGCGAAGGG-3. A plasmid
construct that contained a mutation in the TATA box and in
the ORF50RE was generated using the primers 5V-
CTGCTGTCCCTCGTTTTTCAG GCGTTCCC -
GGCGAAGGG-3 V and 5 V-TGCCCATGTAGGCGTT-
AGCCATTTATGTTCTGGGGCGCGCCAGCG-3V.
For site-directed mutagenesis of K-bZIP, mutagenic oli-
gonucleotides were designed to change various leucine
amino acids within the leucine zipper domain of the protein
using Quick Change mutagenesis kit (Stratagene). Plasmid
pLZ8-1, which contains a mutation in leucine (a) aa 191, was
generated using the primer 5V-AAAGCATACACAAGA-
CAGCTGCAGCAGGCATGGGAAGAA-3V. Plasmid
pLZ8-2, which contains mutations in leucine (a) aa 191
and (b) aa 198, was generated using primer 5V-AAGGATG-
CACAACAATGTTTCCAAGCGGCGAGATCC-
GAGGCA-3V. Plasmid pLZ8-3, which contains mutations in
leucine (e) aa 215 and (f) aa 219, was generated using the
primer 5V-CATAAGGAACAGATTATTTTCCAACGCGA-
CATGCaaATGCGAATGTGCCAGCAG-3V. Plasmid pLZ8-
4, which contains mutations in leucine (b) aa 198, (c) aa 201,
(d) aa 205, (e) aa 215, and (f) aa 219, was generated using
primers 5 V-AAGGATGCACAACAATGTTTCCAA-
GCGGCGAGATCCGAGGCA-3Vand 5V-CATAAGGAACA-
GATTATTTTCCAACGCGACATGCAAATGC -
GAATGTGCCAGCAG-3V.
Transfection–replication assay
Transient replication assay was performed as described
previously (AuCoin et al., 2002).
Cotransfection replication assay
Vero cells (1  105) were plated in 6-cm dishes 24
h before transfection in DMEM and 10% FBS. Two
micrograms of each replication gene plasmid and 10 Ag
of pDA13 were added into a 5-ml polystyrene tube
followed by the addition of 0.5 ml of 0.25 M CaCl2
and then 2  BES-buffered saline (50 mM N,N-bis(2-
hydroxyethyl)-2-aminoethanesulfonic acid [BES], 280 mM
NaCl, 1.5 mM Na2HPO4, pH 6.95). After vortexing
briefly, this mixture was added dropwise to cells. Trans-
fections were incubated for 15 h in a 3% CO2 incubator.
Cells were washed 3 times in medium containing 10%
FBS and total cellular DNA was harvested 96 h post-
transfection using Purgene DNA isolation solutions (Gen-
tra Systems). Ten micrograms of DNA was cleaved with
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on a 0.8% agarose gel. The DNA was transferred to a
nylon membrane and hybridized with 32P-labeled
pGEM7zf(). Membranes were washed and exposed to
X-ray film for 14 h at 80 jC.
Western blot
Five micrograms of plasmid DNA was transfected into
COS7 cells using Transit-LT according to the manufactur-
er’s instructions. Total protein was harvested 48 h post-
transfection and separated using a 10% SDS-PAGE gel.
Proteins were transferred to Immobilon-P membrane and
reacted with anti-FLAG antibody (Sigma). Proteins were
detected by chemiluminescence using Super Signal West
Dura substrate (Pierce).
Northern blot
One million BCBL-1 cells were transfected (electro-
poration) with 10 Ag of pSK50, and total cellular RNA was
extracted using TriZol (Invitrogen) 96 h post-transfection.
For samples treated with PFA (500 Ag/ml), cells were
incubated with drug immediately following electroporation.
RNA samples were treated with DNAse I before electro-
phoreses. RNA was separated on a 1.5% formaldehyde
agarose gel and transferred to Zeta-Probe Nylon membrane
(BioRad). Blots were hybridized using riboprobes in hy-
bridization buffer (1.5 SSPE, 1% SDS, 50% formamide,
0.5% nonfat dried milk, 100 Ag/ml of denatured salmon
sperm DNA, and 50 Ag/ml of yeast tRNA) at 60 jC for
13 h. Blots were washed 2 times for 15 min with 2 SSC,
0.1% SDS at room temperature followed by 2 times for 30
min with 0.1 SSC, 0.1% SDS at 60 jC. Membranes were
exposed to X-ray film for 10 h at 80 jC.
Riboprobes were generated from PCR amplification
products generated using HHV8 genomic specific sequen-
ces 5V-ACGAGGAGCCCCGGCAGCACCCCAGGA-3Vand
5V-TCCTGGGGTGCTGCCGGGGCTCCTGG-3V. Primers
were made such that the T7 RNA polymerase promoter
was added to the 5V-end of one primer at a time. This was
done so that riboprobes could be generated that were
complementary to either the sense or antisense strand of
viral genomic DNA. Riboprobes were made using a Ribop-
robe System-T7 (Promega) in the presence of 32P-CTP and
purified using a G50 column followed by DNAse I treat-
ment. Samples were heated to 95 jC for 5 min and added to
the hybridization mixture.Acknowledgments
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